Mylan Issues EpiPen Recall Due To Potential Defect

A total of 13 lots is involved in this notice of recall.

The products covered by the recall were distributed by Pfizer Canada between November 2015 and February 2016.

The U.S. recall follows an worldwide recall of roughly 81,000 EpiPens in Australia, New Zealand, Europe and Japan in March. Below is a chart of USA lots being recalled along with their expiration dates.

The auto-injectors may contain a faulty part in one lot of EpiPen and one lot of EpiPen Jr.

EpiPens distributed in the United States are now among the tens of thousands being recalled because they don't work. We also asked Mylan exactly how many lots are now being recalled worldwide and the financial cost, and will pass along any reply.

Patients should keep their existing product until their replacement product can be secured.

Last week, the drug company Mylan issued a recall in seven countries for the EpiPen.

Replacement EpiPens can be obtained from your pharmacy, if it has the auto-injector (or its generic equivalent) in stock. Lot numbers of the affected devices can be found on the FDA website. If you have any additional questions regarding this recall, please contact Mylan Customer Relations at 800-796-9526 or

This voluntary recall is being conducted with the knowledge of FDA.

The EpiPen intervention product administers doses of epinephrine to patients suffering from anaphylaxis resulting from extreme allergic reactions.

  • Zachary Reyes